AAN: Smell Loss Can Persist for Five Months After COVID-19
About half of those with compromised sense of smell during acute phase had not regained sense of smell at average of 150.1 days postdiagnosis
Symptoms ID’d That Should Trigger COVID-19 Testing
Testing people with any of seven key symptoms in the first three days of illness would detect 96 percent of symptomatic cases
Vascular Deaths Down for Diabetes Patients in the U.K.
Cancer is now the leading contributor to death among individuals with diabetes living in England
Amoxicillin-Clavulanate Effective for Outpatients With Diverticulitis
As effective as metronidazole with fluoroquinolone, with reduced risk for one-year Clostridioides difficile infection
Predictors of Death, Discharge ID’d for Diabetes Patients With COVID-19
Younger age, routine metformin therapy, and longer symptom duration on admission positively linked to discharge
FDA: New Variants Mean COVID-19 Vaccines, Tests May Need Tweaking
Agency offers recommendations for companies seeking to modify already-approved vaccines, medicines, and tests so they can remain effective
Risk for Rheumatoid Arthritis Reduced for Patients With T2DM
Reduced risk may be attributable to statin use; no significant association seen for glycemic control, metformin use on RA risk
Cocaine Use, HIV Affect Coronary Plaque Morphology
Cocaine use significantly linked to 23.7 percent of radiomic features identified in plaque; HIV infection linked to 1.3 percent
Deceased Organ Donation Rose Among Blacks but Still Lags
Despite gains in deceased organ donation among racial/ethnic groups in the U.S., substantial racial differences remain
Prevalence of Multiple Chronic Conditions Up Among Veterans
Prevalence of MCC remained higher for male, female veterans after stratification by age and adjustment for sociodemographics
